milnacipran has been researched along with trazodone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Almási, J; Rihmer, Z | 1 |
Ikeda, K; Kobayashi, T; Washiyama, K | 1 |
Avuloglu Yilmaz, E; Unal, F; Yuzbasioglu, D | 1 |
2 review(s) available for milnacipran and trazodone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
2 other study(ies) available for milnacipran and trazodone
Article | Year |
---|---|
Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Barium; Cyclopropanes; Electrophysiology; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Hydrogen-Ion Concentration; Milnacipran; Oocytes; Paroxetine; Plasmids; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Receptor, Adenosine A1; Reverse Transcriptase Polymerase Chain Reaction; Selective Serotonin Reuptake Inhibitors; Trazodone; Xenopus laevis | 2006 |
Evaluation of cytogenetic and DNA damage induced by the antidepressant drug-active ingredients, trazodone and milnacipran, in vitro.
Topics: Adult; Antidepressive Agents; Cells, Cultured; Chromosome Aberrations; Comet Assay; Cyclopropanes; DNA Damage; Dose-Response Relationship, Drug; Female; Healthy Volunteers; Humans; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Milnacipran; Mutagenicity Tests; Sister Chromatid Exchange; Trazodone; Young Adult | 2017 |